The CURE

The Cryptocurrency for Personalized Precision Medicine

Gwen Swan

$99.95 $84.72

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Catalyst Institute
31 July 2025

Finance; Industry & industrial studies; Health systems & services; Artificial intelligence

In The CURE, visionary entrepreneur Gwen Swan unveils a bold new paradigm at the intersection of blockchain, artificial intelligence, and multi-omics healthcare. Chronic and complex diseases-cancer, cardiovascular disorders, genetic and rare conditions, and neurodegenerative illnesses-have long evaded one-size-fits-all therapies. Rising costs, inequitable access, and reactive treatment models leave millions at risk. Swan's groundbreaking thesis is simple but revolutionary: leverage a purpose-built cryptocurrency, CURE, to fund and incentivize truly preventive, precision-tailored miRNA-based treatments, transforming how we pay for, develop, and deliver medicine.

CURE is more than a digital token. It is the financial backbone of the CureLogic AI ecosystem, enabling patients, providers, insurers, and institutions to pre-purchase bespoke, microRNA-signature drug plans at a 50% discount-before disease even takes hold. Each token transaction triggers advanced AI diagnostics that analyze a patient's unique genomics, proteomics, blood chemistry, and environmental factors. Within this data framework, CureLogic's proprietary algorithms sift through 55 million miRNA variants and a 25 million-compound drug library to generate individualized treatment protocols down to precise molecular dosages. The result: therapies tailored to each person's biology, powered by transparent, auditable blockchain payments.

As both a compelling manifesto and a practical playbook, The CURE charts a path toward a future where preventive precision medicine becomes the norm, not the exception. By uniting cutting-edge AI diagnostics, molecular therapeutics, and blockchain-based incentives, Gwen Swan lays the foundation for eliminating the world's deadliest diseases-and for extending healthy, vibrant lives worldwide. Whether you are a clinician, biotech innovator, insurer, or patient advocate, The CURE offers the vision and the tools to participate in this healthcare revolution.

By: Gwen Swan
Imprint: Catalyst Institute
Dimensions: Height: 229mm, Width: 152mm, Spine: 18mm
Weight: 476g
ISBN: 9781037092060
ISBN 10: 1037092066
Pages: 264
Publication Date: 31 July 2025
Audience: General/trade , ELT Advanced
Format: Paperback
Publisher's Status: Active

Gwen Swan is a mathematician, entrepreneur, and visionary leader at the forefront of precisionmedicine and blockchain innovation. As the Founder and Chief Executive Officer of CureLogicAI, Gwen has spearheaded the development of an AI-driven microRNA therapeutics platformthat integrates genomics, proteomics, blood chemistry, and environmental data to produce trulypersonalized drug regimens. Under her leadership, CureLogic has identified over 55 millionmicroRNA strains and built a 25 million-compound library, positioning the company torevolutionize preventive healthcare.Prior to founding CureLogic, Gwen co-founded and led IPPON FinTech, a platform forIP-backed securities trading and valuation, securing seed investments from leading venturecapital firms. She holds advanced degrees in mathematics and applied statistics, and her careerspans roles in business valuation, biotech licensing, and strategic consulting. A publishedauthor on AI governance and decentralized finance, Gwen is passionate about harnessingemerging technologies to eliminate chronic and genetic diseases, extend healthy lifespan, anddemocratize access to life-saving therapies.

PRIZES to win! PROMOTIONS

The CURE

The Cryptocurrency for Personalized Precision Medicine

Gwen Swan

$99.95 $84.72

Paperback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S